Related Experiment Video
Updated: Aug 2, 2026

14:04
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
[Resistance to linezolid in Staphylococcus aureus before its release]
1Gériatrie 3, hôpital Emile-Roux, 94450 Limeil-Brévannes, France. anani.akpabie@erx.ap-hop-paris.fr
Pathologie-Biologie
|October 7, 2004
Summary
Antibiotic resistance is a global concern. In a geriatric center, all Staphylococcus aureus strains tested were susceptible to linezolid before its release, indicating its potential effectiveness against MRSA infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Geriatric Medicine
Context:
- Antibiotic resistance poses a significant challenge in healthcare settings, particularly in geriatric centers.
- Staphylococcus aureus, including methicillin-resistant strains (MRSA), is a common cause of infections in elderly populations.
- The emergence of antibiotic-resistant bacteria necessitates the evaluation of novel therapeutic agents.
Purpose:
- To assess the in vitro susceptibility of Staphylococcus aureus strains to linezolid prior to its introduction in a geriatric facility.
- To determine the prevalence of linezolid resistance in Staphylococcus aureus isolates from elderly patients.
Summary:
- A study analyzed 213 Staphylococcus aureus strains from a geriatric center.
- All strains, including MRSA, demonstrated in vitro susceptibility to linezolid, cotrimoxazole, fosfomycin, and glycopeptides.
- High resistance rates were observed for pefloxacin, tobramycin, and erythromycin among MRSA strains.
Impact:
- Linezolid demonstrated in vitro effectiveness against Staphylococcus aureus, including MRSA, suggesting its potential utility in treating infections in geriatric patients.
- The findings underscore the importance of monitoring linezolid use due to reported clinical resistance.
- This study provides crucial data for guiding the appropriate use of linezolid in managing MRSA infections in elderly care settings.
Related Concept Videos
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

